血液成分疗法在犬猫癌症患者治疗中的作用。
The role of blood component therapy in the management of canine and feline patients with cancer.
作者信息
Rudloff E
机构信息
Veterinary Institute of Trauma, Emergency and Critical Care, Milwaukee, Wisconsin, USA.
出版信息
Vet Clin North Am Small Anim Pract. 1995 Nov;25(6):1403-16. doi: 10.1016/s0195-5616(95)50161-5.
Blood component therapy may be required for a variety of pathologic reasons in the cancer patient. The tumor itself not only affects various cell lines, but treatment with chemotherapeutic agents can induce cytopenias. In addition, chronic and acute hemorrhage can be caused by tumor erosion and rupture or by paraneoplastic coagulopathies. Component replacement will depend on the underlying hematologic deficiencies and should be performed in conjunction with treating the cause of the deficiency.
由于各种病理原因，癌症患者可能需要进行血液成分治疗。肿瘤本身不仅会影响各种细胞系，而且化疗药物治疗可导致血细胞减少。此外，慢性和急性出血可能由肿瘤侵蚀、破裂或副肿瘤性凝血病引起。成分替代将取决于潜在的血液学缺陷，并且应在治疗缺陷原因的同时进行。
Zotero 插件